Navigation Links
Genetic Testing Explodes after Supreme Court Patent Decision
Date:8/20/2013

NEW YORK, Aug. 20, 2013 /PRNewswire-iReach/ -- Within weeks of the Supreme Court's historic decision declaring that human genes cannot be patented, two scientists have started a company that will democratize the human genome and give people direct access to their own genetic information – which can have an immediate impact on their health and well being. The court's decision spurred the two scientists, Christopher Mason, PhD, of Weill Cornell Medical College, and Jeffrey Rosenfeld, PhD, of Rutgers Medical School, to form Genome Liberty and begin offering immediate, personalized genetic testing directly to the public – although the results should used in concert with a doctor. 

(Photo:  http://photos.prnewswire.com/prnh/20130820/MN65902)

"The Supreme Court's decision opened an era of genomic liberty, allowing people to look at the DNA for all of their genes – which had been hidden behind patent walls for companies that had a monopoly on such testing," Mason said. "Our next-generation sequencing technology allows individuals to be proactive in understanding how their genome can affect their health decisions."

Previously, individuals had to rely on their doctors to understand their health and to make proper medical decisions for them. As scientists and doctors have found the molecular basis for disease and drug response, it has become increasingly clear that a "one-size-fits-all" framework for medicine is not in patients' best interest.

"Genome Liberty fills an important void in our current medical system," Rosenfeld said. "For example, there are clear genetic markers for many medications that will determine whether a person will respond properly or may have extreme side-effects, including estrogen, codeine, Plavix, Nexium, Prilosec, Zocor, Dilantin, Coumadin, Hal
'/>"/>

SOURCE Genome Liberty
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BellBrook Labs Launches Second Generation Transcreener EPIGEN Methyltransferase Assay to Acclerate Epigenetic Drug Discovery
2. Epigenetic and MicroRNA Biomarkers 2013 Market Report
3. Population Genetics Assigns Asymmetric Adaptor Library Construction Patent To New England Biolabs
4. Cytogenetics - Technologies, Markets and Companies - 2013
5. Genetic Engineering: A New Use for Algae in Biofuel Production
6. Signal Genetics Announces Publication of BreastPRS™ Validation Study with Weill Cornell Medical College, New York
7. Signal Genetics LLC Announces Update to MyPRS™ Gene Expression Profiling Assay for Multiple Myeloma
8. BellBrook Labs and Tecan Offer Webinar on Screening Epigenetic Targets
9. Todays Technical View: Elan Corp., Amarin, Seattle Genetics, and Cubist Pharma
10. RiboMed and Austrian Institute of Technology Partner on Epigenetic Tests for Early Lung Cancer Detection, Sub-typing and Drug Response
11. Cellular Dynamics International Expands MyCell Products Line with Disease Models, Genetic Engineering Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 2015 Sinovac Biotech Ltd. (Nasdaq: SVA), a ... its unaudited financial results for the fourth quarter and ... Quarter 2014 Financial Highlights(Compared to the fourth quarter 2013) ... decrease of 11.4% from $22.9 million in the prior ... H5N1 pandemic influenza vaccine of $0.1 million in the ...
(Date:4/17/2015)... ALTO, Calif. , April 17, 2015 ... has received a SBIR grant from the ... the National Institutes of Health (NIH). The ... research efforts in the development of breakthrough ... genomes using specially fabricated substrates. Centrillion has ...
(Date:4/17/2015)... , April 17, 2015  US-Australian drug discovery ... a Memorandum of Understanding with the Feinstein Institute ... New York to collaborate with the ... The collaboration brings together the drug ... clinical expertise of the Feinstein Institute in neurosciences ...
(Date:4/16/2015)... and OSAKA, Japan , ... Research Application (CiRA) of Kyoto University and Takeda ... will work together to develop clinical applications of ... heart failure, diabetes mellitus, neurological disorders and cancer ... Applications" (T-CiRA) is designed to expedite multiple research ...
Breaking Biology Technology:Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 2Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 3Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 4Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 5Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 6Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 7Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 8Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 9Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 10Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 11Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 12Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 13Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 14Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 15Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 16Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 17Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 18Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 2Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 3Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 4Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 5Novogen and Feinstein Institute Join Forces to Find Effective Treatments for Brain Cancer 6CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 2CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 3
... Janesville, Wis. - Fighting cancer and disposing of ... first glance. However, a small company in Janesville has ... tackle both problems simultaneously. , , NorthStar Nuclear Medicine, ... an agent for cancer research and treatment by processing ...
... between the University of Wisconsin-Madison and the ... shown that thousands of sleeping computers can unravel the ... a program first developed at Technion for identifying the ... families, has since grown to operate on 200 computers ...
... a developer of radiation therapy technology, has installed its second ... medical center based in Duarte, Calif. , ,The facility, a ... a growing number of treatment centers that have purchased a ... able to produce a 3-dimensional image of a tumor and ...
Cached Biology Technology:NorthStar finds cancer-fighting use for nuclear fuel 2UW links with Israeli school to locate genes 2UW links with Israeli school to locate genes 3
(Date:3/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) has ... Market 2015-2019" report to their offering. ... grow at a CAGR of 23.5 percent over the ... scenario and the growth prospects of the Global Iris ... market size, the report considers the revenue generated from ...
(Date:3/24/2015)... BEACH GARDENS, Fla. , March 24, 2015 ... biometric identity management solutions, today announced that its ... premium clothing accessory retailer Goorin Bros . ... The Crossmatch biometrics-based solution secures access to the ... from the increased risk of data breaches. ...
(Date:3/23/2015)... LOS ANGELES , March 23, 2015  In ... in Federal fraud case conviction losses. This figure accounts ... fraud, which, according to The Nilson Report, exceeds $11 ... an investigative tool after a crime has occurred. Investor ... Agent and polygraph expert Joe Paolella partnered ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... German . , Mild environmental conditions are a ... high concentrations are detrimental to both humans and to simpler ... that all biological functions in the cells come to a ... hostile conditions where we still find life? Scientists at the ...
... shows that the world is losing the battle over ... and human well-being. Published online today in the ... and the Environment , the review concludes we are ... immediate global, multi-pronged conservation approach to avert the worst ...
... help forge an agenda for maintaining the independence of ... corporate influence. Dr. James Hansen, Director of the NASA ... "Threat to the Planet: The Dark and Bright Sides ... leading authority on climate change and the need to ...
Cached Biology News:Purple extremist thrives under inhospitable conditions 2Purple extremist thrives under inhospitable conditions 3Looming tropical disaster needs urgent action 2NASA scientist James Hansen to speak at July 11 conference on 'Rejuvenating Public Sector Science' 2
Mouse monoclonal antibody raised against a partial recombinant JRKL. NCBI Entrez Gene ID = JRKL...
Mouse monoclonal antibody to ST8SIA2 - ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2...
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Mouse monoclonal antibody raised against a partial recombinant RAB11B. NCBI Entrez Gene ID = RAB11B...
Biology Products: